Medical Oncologist
CION Cancer Clinics
Surveillance for hereditary cancer risk: the complete picture | CION Cancer Clinics
Carrying a cancer gene fault changes how, and how often, certain organs are watched. This page lays out what a surveillance programme actually is, which organs it usually covers, how a plan is built around your specific gene, and how it differs from screening built for the general population. At CION Cancer Clinics, our team helps carriers and their families plan checks, next steps and support after a genetic result.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does surveillance actually mean for a carrier?
- What a surveillance plan usually covers
- From your gene report to your first appointment
- Words your surveillance letter will use
- Surveillance and risk-reducing surgery, compared
- What this page cannot tell you
- Four things carriers tell us, and what is actually true
- Common questions about surveillance programmes
The short answer
What does surveillance actually mean for a carrier?
Surveillance means watching specific organs more closely, and earlier, than a person without a known gene fault would be watched. It is not one test. It is a schedule of scans, blood work and examinations that repeats for as long as it is needed, built around the exact gene involved.
Why the schedule looks different for you
General population screening is built for one risk level shared by almost everyone. A carrier's risk is higher for particular organs and starts earlier in life, so a general schedule misses too much. Your programme is set against the gene, not against a birthday everyone shares.
It is a programme, not a single test
A mammogram once is screening. A mammogram and an MRI on a fixed cycle, reviewed every year by the same clinic, is surveillance. The point is not any one result. It is catching a change early enough that treatment is simpler and outcomes are better.
Surveillance does not lower your risk of developing cancer. It raises the chance of finding it while it is still easy to treat.One programme, several organs
What a surveillance plan usually covers
Which organs are on your list depends entirely on the gene. Nobody is screened everywhere just because one fault was found.
Breast
Usually the earliest and most closely watched organ for the genes that raise breast cancer risk, combining mammography with breast MRI on a fixed cycle.
Ovary and gynaecological organs
Watched less confidently, because current tools catch relatively little early. Risk-reducing surgery is discussed alongside surveillance for this reason, not instead of it.
Bowel and upper digestive tract
Colonoscopy, and sometimes an upper endoscopy, on an interval set by the syndrome rather than by age alone.
Often paired with
- Polyp removal during the same procedure
- A shorter interval if polyps are found
Skin, thyroid, kidney and pancreas
Added only where the specific gene carries that risk. A syndrome that raises kidney cancer risk does not automatically add a pancreas scan, and the reverse is also true.
Not sure whether this applies to you?
Ask an oncologistHow a plan is built
From your gene report to your first appointment
-
The gene is identified
A genetic counsellor confirms exactly which fault you carry. Different genes on the same panel can carry completely different surveillance needs.
-
Organs at risk are mapped
Your counsellor or specialist lists every organ that gene is known to affect, drawing on published guidelines rather than guesswork.
-
Starting ages are set individually
Your own family's youngest diagnosis can move your starting age earlier than the guideline default. This is discussed at your first planning visit.
-
A named clinic takes ownership
One team coordinates the whole schedule so results are compared year on year, rather than each scan being read on its own.
-
The plan is reviewed, not fixed forever
Guidelines change and your own results feed back into the plan. What you are given today is reviewed again at your next visit.
On your report
Words your surveillance letter will use
- Enhanced surveillance
- Screening that starts earlier and repeats more often than the general population schedule, because of a known raised risk.
- Baseline
- Your first scan on the programme, used as the picture everything afterwards is compared against.
- Interval
- The gap between one scan and the next. It is set by the syndrome, not chosen at random, and shortens if something needs a closer look.
- Multidisciplinary clinic
- A clinic where the specialists relevant to your gene review your results together, instead of you carrying reports between departments.
- Risk-reducing surgery
- Removing an organ before cancer develops in it. It is one option alongside surveillance for some genes, not a replacement for all screening.
- Penetrance
- How often a fault actually leads to cancer across everyone who carries it. Surveillance plans are built around this figure for each gene.
Side by side
Surveillance and risk-reducing surgery, compared
Surveillance
Risk-reducing surgery
The organ stays; risk is not removed
The organ is removed; risk from it largely goes with it
Requires attending appointments for life
One operation, then ordinary recovery
Suits organs where scans catch disease early
Considered where scans catch too little, such as the ovary
Reversible in the sense that nothing is removed
Permanent, and carries its own recovery and effects
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being straight with you
What this page cannot tell you
It cannot tell you your own schedule. That depends on your exact gene, your family's youngest diagnosis, and organs already treated. It is set by a genetic counsellor or specialist who has your full history in front of them, not by a general description.
It cannot replace a missed appointment
A surveillance programme only works if it is followed. A scan that is postponed by a year is not the same programme with a small delay. It is a gap in the record that makes the next result harder to read correctly.
Who this does not apply to
Most people with some cancer in the family have not been found to carry a single gene fault, and enhanced surveillance of this kind is not what they need. It is built for confirmed carriers and, in some syndromes, their untested first-degree relatives.
If you are not sure whether you are on the right programme, call the helpline and describe your gene and your family history.Commonly believed
Four things carriers tell us, and what is actually true
"I feel completely well, so I can skip this year."
Surveillance exists precisely because early cancer usually causes no symptoms at all. Feeling well is the expected state right up until a scan finds something, which is the whole point of looking before symptoms appear.
"Surveillance stops me getting cancer."
It does not lower your risk. It raises the chance a cancer is caught while it is small and easier to treat. Prevention and early detection are different jobs, and surveillance only does the second one.
"One clear scan means I am in the clear now."
A clear result describes that one moment. The underlying gene fault has not changed, so the next scan on schedule matters just as much as this one did.
"Everyone with this gene follows the same plan."
Two people with the same fault can be offered different schedules, based on which relatives were affected, at what age, and which organs are already treated. There is no single plan that fits a gene name alone.
Questions we are asked
Common questions about surveillance programmes
Is surveillance the same as a routine health check-up?
No. A routine check-up is built for someone with an average risk. Surveillance is built around a specific gene, so it starts earlier, repeats more often, and looks at organs a standard check-up would not examine at all.
Do I need every test in this programme?
Only the ones relevant to your gene. A fault that raises breast cancer risk does not automatically add a colonoscopy, and the reverse is also true. Your plan lists only the organs your specific gene is known to affect.
Who actually manages the schedule?
Usually a named multidisciplinary clinic rather than one doctor working alone. That team keeps the record, sends reminders, and compares each new result against your earlier ones rather than reading it in isolation.
What happens if I miss a scan?
Book the next one as soon as you can rather than waiting for the next scheduled date. A missed scan is a gap in the record, and the sooner it is filled the sooner the programme is back on track.
Does surveillance ever stop?
For most inherited cancer genes it continues for life, sometimes changing in intensity as you age or after risk-reducing surgery removes one organ from the list. Very few programmes end outright.
Can surveillance replace risk-reducing surgery?
For some organs, yes, and it is the preferred choice for most carriers. For organs where scans catch too little, such as the ovary, surgery is usually discussed as well, not as a replacement for watching but alongside it.
Will Aarogyasri or my insurer cover this?
Cover varies by scheme, by scan, and by whether it is classed as preventive or diagnostic. Ask the billing desk to check your specific scheme against each test before your appointment, rather than assuming either way.
Where do I start if nobody has explained my plan?
Call the CION helpline with your gene report in hand. Someone will connect you to a genetic counsellor who can lay out exactly which organs apply to you and on what interval.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Sources
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
- NCCN — NCCN Guidelines for Patients: Genetic Testing for Hereditary Cancer
- Cancer Research UK — Inherited cancer genes and increased cancer risk
- NHS — Predictive genetic tests for cancer risk genes
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
At what age should screening start?How your own starting age is actually setThe ten-year rule explainedWhy a young diagnosis in the family moves your schedule earlierWhat happens when surveillance finds somethingWhat follows an abnormal result on this kind of programmeA printable personal surveillance planA way to keep every organ's schedule in one place
Talk to us
Not sure what your surveillance plan should include?
Tell us which gene fault is in your report and we will connect you with a genetic counsellor who can map out the organs that apply to you. One helpline serves every CION centre.